Skip to main content
The entry hall inside House of Rose Aesthetics in Punta Gorda, Florida
The Journal

Treatment questions, answered with sources.

Each article focuses on one treatment question, links the sources behind the answer, and makes the limits of that evidence easy to see.

Check the evidence

You should be able to check the original for yourself.

The current Morpheus8 article links directly to the FDA safety communication and patient information it discusses. You can read the agency’s wording and the date of the safety communication—not only House of Rose’s summary.

The article also separates a reported risk from a prediction about every procedure, then turns the source material into practical questions about the treatment area, practitioner, recovery, and follow-up.

Current article

Morpheus8 safety questions grounded in FDA information.

The current article reviews FDA safety communications, the questions worth asking about the treatment area and device, and the limits of what an article can establish for one person.

What the source cannot answer

An FDA safety communication is not a recommendation for your treatment plan.

The FDA communication identifies reported complications and advises patients what to ask before RF microneedling. It does not determine whether a particular treatment area, depth, or energy setting is appropriate for one person, and it cannot predict individual recovery. If you are considering Morpheus8, ask who would perform it, which area and settings are proposed, what recovery and follow-up may involve, and what alternatives exist before deciding.